Back to search

Article

“SARS-CoV-2 antibody seroprevalence and stability in a tertiary care hospital-setting”

2020-09-03

Abstract excerpt

<h4>Background</h4> SARS-CoV-2 infection has caused 64,469 deaths in India, with 7, 81, 975 active cases till 30 th August 2020, lifting it to 3 rd rank globally. To estimate the burden of the disease with time it is important to undertake a longitudinal seroprevalence study which will also help to understand the stability of anti SARS-CoV-2 antibodies. Various studies have been conducted worldwide to assess the a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
22febd48-3eea-5759-b2ae-86c4da394834
DOI
10.1101/2020.09.02.20186486
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
“SARS-CoV-2 antibody seroprevalence and stability in a tertiary care hospital-setting”DOI 10.1101/2020.09.02.20186486
SARS-CoV-2 Antibody Seroprevalence and Stability in a Tertiary Care Hospital-SettingSemantic proximity
Serial SARS-CoV-2 Seropravelence Studies in Delhi July-August 2020: Indications of Pre-existing Cross-reactive Antibodies and Implications for Disease ProgressionSemantic proximity
Prevalence of Igg Antibodies Against SARS-CoV-2 Among the General Population and Healthcare Workers in India, June–July 2021Semantic proximity
SARS-CoV-2 seroprevalence in Delhi, India - September-October 2021 – a population based seroepidemiological studySemantic proximity
The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide survey in Karnataka, IndiaSemantic proximity
Performance Assessment of First-Generation Anti-SARS-CoV-2 Serological AssaysSemantic proximity
Prevalence of IgG Antibodies to SARS-CoV-2 in Wuhan – Implications for the Longevity of Antibodies Against SARS-CoV-2Semantic proximity
Second round statewide survey for estimation of the burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population of Karnataka, IndiaSemantic proximity
SARS-CoV-2 Sero-Prevalence Among General Population and Healthcare Workers in India, December 2020 - January 2021Semantic proximity
ANTI - SARS-CoV-2 ANTIBODY SCREENING IN HEALTH CARE WORKERS AND ITS CORRELATION WITH CLINICAL PRESENTATIONSemantic proximity
SARS-CoV-2 Antibody Prevalence in India: Findings from the Second Nationwide Household Serosurvey, August - September 2020Semantic proximity
The prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-upSemantic proximity
Select a neighboring publication to make it the new centre.